{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:53:35Z","timestamp":1707296015143},"reference-count":9,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134430","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T18:01:01Z","timestamp":1438279261000},"page":"e0134430","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir\/Emtricitabine\/Rilpivirine: A W96 Follow-Up"],"prefix":"10.1371","volume":"10","author":[{"given":"Charlotte","family":"Charpentier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Patrick","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Visseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Lariven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Phung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Y\u00e9ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Landman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0000000000000087","article-title":"Simplification to rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants","volume":"28","author":"FJ Palella Jr","year":"2014","journal-title":"AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1310\/hct1405-216","article-title":"Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine\/tenofovir disoproxil fumarate-based single-tablet regimens","volume":"14","author":"AM Mills","year":"2013","journal-title":"HIV Clin Trials"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry","volume":"21","author":"BH Jung","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"ref4","unstructured":"Brochot A, De La Rosa G, Vis P, Corbett C, Vanveggel S, Cohen CJ, et al. Generalised additive modelling of virologic response to the NNRTIs rilpivirine (RPV, TMC278) and efavirenz (EFV) in treatment-na\u00efve HIV-infected patients: pooled data from ECHO and THRIVE. In: Abstracts of the thirteen European AIDS Clinical Society AIDS Conference, Belgrad, Serbia, 2011. Abstract PS12\/7."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1097\/QAD.0000000000000387","article-title":"Skeletal muscle toxicity associated with emtricitabine\/rilpivirine\/tenofovir fixed-dose combination: a case report","volume":"28","author":"LB Nguyen","year":"2014","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/hiv.12183","article-title":"Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study","volume":"16","author":"P Gantner","year":"2015","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"ref7","first-page":"A122","article-title":"One year follow-up of 275 virologically-suppressed patients switching to RPV\/TDF\/FTC, ANRS CO3 Aquitaine Cohort","volume":"19","author":"S Reigadas","year":"2014","journal-title":"Antivir Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/jac\/dku294","article-title":"Initiation of rilpivirine, tenofovir and emtricitabine (RPV\/TDF\/FTC) regimen in 363 patients with virological vigilance assessment in 'real life'","volume":"69","author":"C Amiel","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/jac\/dku187","article-title":"Switching from tenofovir\/emtricitabine and nevirapine to a tenofovir\/emtricitabine\/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjects","volume":"69","author":"C Allavena","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:48:12Z","timestamp":1589024892000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134430"}},"subtitle":[],"editor":[{"given":"Cristian","family":"Apetrei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134430","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}